Akeso says its closely watched drug improved patient survival in a lung cancer trial
Posted:
Akeso, a Chinese biotech with a drug positioned to rival Merck’s megablockbuster Keytruda, has reported for the first time that the therapy can improve patient survival.
OpenAI is expanding ChatGPT's healthcare capabilities with a new integration that connects Epic electronic health records (EHRs) to ChatGPT for Healthcare and a plugin that gives care providers access to public healthcare data sources.
The Epic integration lets clinicians bring patient information into…
Updated migraine prevention guidance incorporates calcitonin gene-related peptide (CGRP)-targeted therapies and places greater emphasis on individualized treatment selection based on patient priorities.
Preventive therapy should be offered to those with at least 4 migraine days per month, at least 4 moderate-to-severe headache days per…
Attendees
Sponsors and Exhibitors
Contact us